| Published Application/Species/Sample/Dilution | Reference |
|---|
- immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig s8d
- immunocytochemistry; human; 1:200; loading ...; fig s7a
| Taparra K, Wang H, Malek R, Lafargue A, Barbhuiya M, Wang X, et al. O-GlcNAcylation is required for mutant KRAS-induced lung tumorigenesis. J Clin Invest. 2018;128:4924-4937 pubmed publisher |
| Czajewski I, Swain B, Xu J, McDowall L, Ferenbach A, van Aalten D. Rescuable sleep and synaptogenesis phenotypes in a Drosophila model of O-GlcNAc transferase intellectual disability. elife. 2024;13: pubmed publisher |
| Authier F, Ondruskova N, Ferenbach A, McNeilly A, van Aalten D. Neurodevelopmental defects in a mouse model of O-GlcNAc transferase intellectual disability. Dis Model Mech. 2024;17: pubmed publisher |
| Omelkov xe1 M, Fenger C, Murray M, Hammer T, Pravata V, Bartual S, et al. An O-GlcNAc transferase pathogenic variant linked to intellectual disability affects pluripotent stem cell self-renewal. Dis Model Mech. 2023;16: pubmed publisher |
| Feng Z, Wang T, Sun Y, Chen S, Hao H, Du W, et al. Sulforaphane suppresses paraquat-induced oxidative damage in bovine in vitro-matured oocytes through Nrf2 transduction pathway. Ecotoxicol Environ Saf. 2023;254:114747 pubmed publisher |
| Kadosaka T, Watanabe M, Natsui H, Koizumi T, Nakao M, Koya T, et al. Empagliflozin attenuates arrhythmogenesis in diabetic cardiomyopathy by normalizing intracellular Ca2+ handling in ventricular cardiomyocytes. Am J Physiol Heart Circ Physiol. 2023;324:H341-H354 pubmed publisher |
| Jo R, Shibata H, Kurihara I, Yokota K, Kobayashi S, Murai Takeda A, et al. Mechanisms of mineralocorticoid receptor-associated hypertension in diabetes mellitus: the role of O-GlcNAc modification. Hypertens Res. 2023;46:19-31 pubmed publisher |
| Ise H, Araki Y, Song I, Akatsuka G. N-acetylglucosamine-bearing polymers mimicking O-GlcNAc-modified proteins elicit anti-fibrotic activities in myofibroblasts and activated stellate cells. Glycobiology. 2023;33:17-37 pubmed publisher |
| Kumar A, Yarosz E, Andren A, Zhang L, Lyssiotis C, Chang C. NKT cells adopt a glutamine-addicted phenotype to regulate their homeostasis and function. Cell Rep. 2022;41:111516 pubmed publisher |
| Zhu W, Palazzo T, Zhou M, Ledee D, Olson H, Pa x161 a Toli x107 L, et al. First comprehensive identification of cardiac proteins with putative increased O-GlcNAc levels during pressure overload hypertrophy. PLoS ONE. 2022;17:e0276285 pubmed publisher |
| Shi Q, Shen Q, Liu Y, Shi Y, Huang W, Wang X, et al. Increased glucose metabolism in TAMs fuels O-GlcNAcylation of lysosomal Cathepsin B to promote cancer metastasis and chemoresistance. Cancer Cell. 2022;40:1207-1222.e10 pubmed publisher |
| Wang T, Feng Z, Sun Y, Zhao S, Zou H, Hao H, et al. Disruption of O-GlcNAcylation Homeostasis Induced Ovarian Granulosa Cell Injury in Bovine. Int J Mol Sci. 2022;23: pubmed publisher |
| Guilloteau E, Coll P, Lu Z, Djouina M, Cazaunau M, Waxin C, et al. Murine in utero exposure to simulated complex urban air pollution disturbs offspring gut maturation and microbiota during intestinal suckling-to-weaning transition in a sex-dependent manner. Part Fibre Toxicol. 2022;19:41 pubmed publisher |
| Raab S, Very N, Duch xea ne B, Rybarczyk P, Jonckheere N, El Yazidi Belkoura I, et al. Evaluation of the expression of fatty acid synthase and O-GlcNAc transferase in patients with liver cancer by exploration of transcriptome databases and experimental approaches. Oncol Lett. 2022;23:105 pubmed publisher |
| Ishikita A, Matsushima S, Ikeda S, Okabe K, Nishimura R, Tadokoro T, et al. GFAT2 mediates cardiac hypertrophy through HBP-O-GlcNAcylation-Akt pathway. iScience. 2021;24:103517 pubmed publisher |
| Ogawa Y, Imamoto N. Methods to separate nuclear soluble fractions reflecting localizations in living cells. iScience. 2021;24:103503 pubmed publisher |
| Song T, Zou Q, Yan Y, Lv S, Li N, Zhao X, et al. DOT1L O-GlcNAcylation promotes its protein stability and MLL-fusion leukemia cell proliferation. Cell Rep. 2021;36:109739 pubmed publisher |
| Muha V, Authier F, Szoke Kovacs Z, Johnson S, Gallagher J, McNeilly A, et al. Loss of O-GlcNAcase catalytic activity leads to defects in mouse embryogenesis. J Biol Chem. 2021;296:100439 pubmed publisher |
| Murakami K, Kurotaki D, Kawase W, Soma S, Fukuchi Y, Kunimoto H, et al. OGT Regulates Hematopoietic Stem Cell Maintenance via PINK1-Dependent Mitophagy. Cell Rep. 2021;34:108579 pubmed publisher |
| Martínez Fábregas J, Wang L, Pohler E, Cozzani A, Wilmes S, Kazemian M, et al. CDK8 Fine-Tunes IL-6 Transcriptional Activities by Limiting STAT3 Resident Time at the Gene Loci. Cell Rep. 2020;33:108545 pubmed publisher |
| Decourcelle A, Very N, Djouina M, Loison I, Thevenet J, Body Malapel M, et al. O-GlcNAcylation Links Nutrition to the Epigenetic Downregulation of UNC5A during Colon Carcinogenesis. Cancers (Basel). 2020;12: pubmed publisher |
| Nomura A, Yokoe S, Tomoda K, Nakagawa T, Martín Romero F, Asahi M. Fluctuation in O-GlcNAcylation inactivates STIM1 to reduce store-operated calcium ion entry via down-regulation of Ser621 phosphorylation. J Biol Chem. 2020;295:17071-17082 pubmed publisher |
| Mercier T, Bouvet M, Dubois Deruy E, Dechaumes A, Beseme O, Richard V, et al. Interplay Between Phosphorylation and O-GlcNAcylation of Sarcomeric Proteins in Ischemic Heart Failure. Front Endocrinol (Lausanne). 2018;9:598 pubmed publisher |
| Taub D, Awal M, Gabel C. O-GlcNAc Signaling Orchestrates the Regenerative Response to Neuronal Injury in Caenorhabditis elegans. Cell Rep. 2018;24:1931-1938.e3 pubmed publisher |
| Hugo S, Schlegel A. A Genetic Model to Study Increased Hexosamine Biosynthetic Flux. Endocrinology. 2017;158:2420-2426 pubmed publisher |
| Shin G, Kang H, Lee A, Kim K. Hepatitis B virus-triggered autophagy targets TNFRSF10B/death receptor 5 for degradation to limit TNFSF10/TRAIL response. Autophagy. 2016;12:2451-2466 pubmed |
| Swamy M, Pathak S, Grzes K, Damerow S, Sinclair L, van Aalten D, et al. Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy. Nat Immunol. 2016;17:712-20 pubmed publisher |
| Allen J, Crowder R, Crowder R, El Deiry W. First-In-Class Small Molecule ONC201 Induces DR5 and Cell Death in Tumor but Not Normal Cells to Provide a Wide Therapeutic Index as an Anti-Cancer Agent. PLoS ONE. 2015;10:e0143082 pubmed publisher |
| Liu Y, Hawkins O, Vilgelm A, Pawlikowski J, Ecsedy J, Sosman J, et al. Combining an Aurora Kinase Inhibitor and a Death Receptor Ligand/Agonist Antibody Triggers Apoptosis in Melanoma Cells and Prevents Tumor Growth in Preclinical Mouse Models. Clin Cancer Res. 2015;21:5338-48 pubmed publisher |
| Stateva S, Villalobo A. O-GlcNAcylation of the human epidermal growth factor receptor. Org Biomol Chem. 2015;13:8196-204 pubmed publisher |
| Foster K, Jane E, Premkumar D, Morales A, Pollack I. NVP-BKM120 potentiates apoptosis in tumor necrosis factor-related apoptosis-inducing ligand-resistant glioma cell lines via upregulation of Noxa and death receptor 5. Int J Oncol. 2015;47:506-16 pubmed publisher |
| Talekar M, Allen J, Dicker D, El Deiry W. ONC201 induces cell death in pediatric non-Hodgkin's lymphoma cells. Cell Cycle. 2015;14:2422-8 pubmed publisher |
| Shibutani M, Mori T, Miyano T, Miyake M. Removal of O-GlcNAcylation is important for pig preimplantation development. J Reprod Dev. 2015;61:341-50 pubmed publisher |
| Prabhu V, Allen J, Dicker D, El Deiry W. Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem-like Cells in an Akt/Foxo3a/TRAIL-Dependent Manner. Cancer Res. 2015;75:1423-32 pubmed publisher |
| Itkonen H, Minner S, Guldvik I, Sandmann M, Tsourlakis M, Berge V, et al. O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells. Cancer Res. 2013;73:5277-87 pubmed publisher |
| Dias W, Cheung W, Hart G. O-GlcNAcylation of kinases. Biochem Biophys Res Commun. 2012;422:224-8 pubmed publisher |
